Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Nov 21;174(1):197–208. doi: 10.1007/s10549-018-5050-1

Fig. 2.

Fig. 2

Direct adjusted rates (continuous endocrine therapy use) at year 1 of follow-up were calculated from final multivariable discontinuation Cox model, with 95% confidence interval, including adjustments for stage, age, year of diagnosis, race, ethnicity, and 3-year NCI modified comorbidity index